Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-08

Clinical Trial Update: Percutaneous Gelled Alcohol Sclerotherapy for Aggressive Angiomas: Evaluation of Feasibility, Safety, and Efficacy

View source ↗

Summary

This clinical trial update describes a study evaluating percutaneous gelled alcohol sclerotherapy for aggressive bone angiomas, focusing on feasibility, safety,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Bone Angioma | Status: RECRUITING